Published in Biomed Res Int on February 02, 2014
Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Immunosuppressive Microenvironment. Biomed Res Int (2015) 0.81
Crosstalk of carcinoembryonic antigen and transforming growth factor-β via their receptors: comparing human and canine cancer. Cancer Immunol Immunother (2015) 0.81
Therapeutic Touch Has Significant Effects on Mouse Breast Cancer Metastasis and Immune Responses but Not Primary Tumor Size. Evid Based Complement Alternat Med (2015) 0.79
Breast cancer survival among young women: a review of the role of modifiable lifestyle factors. Cancer Causes Control (2016) 0.77
Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer. Cancer Immunol Immunother (2016) 0.75
Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine. Oncol Lett (2016) 0.75
A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs. Biomed Res Int (2016) 0.75
Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors. Anal Cell Pathol (Amst) (2015) 0.75
Tumor reductive therapies and antitumor immunity. Oncotarget (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Immunity, inflammation, and cancer. Cell (2010) 28.27
Inflammation and cancer: back to Virchow? Lancet (2001) 27.40
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54
Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature (2005) 23.04
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med (2003) 16.62
Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med (2005) 12.64
Origin and physiological roles of inflammation. Nature (2008) 11.68
Paradoxical roles of the immune system during cancer development. Nat Rev Cancer (2006) 10.57
Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol (2009) 9.41
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol (2001) 7.43
Natural innate and adaptive immunity to cancer. Annu Rev Immunol (2011) 7.09
Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol (2011) 6.13
Cancer immunology. N Engl J Med (2008) 5.22
Inflammation and cancer: how hot is the link? Biochem Pharmacol (2006) 5.17
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood (2009) 4.80
"Re-educating" tumor-associated macrophages by targeting NF-kappaB. J Exp Med (2008) 4.38
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res (2007) 3.76
Regulatory T cells: how do they suppress immune responses? Int Immunol (2009) 3.58
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer (2011) 3.45
Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res (2008) 3.09
Inflammatory cells and cancer: think different! J Exp Med (2001) 2.42
Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab Invest (1996) 2.31
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers. Breast Cancer Res (2009) 2.26
Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Breast Cancer Res (2011) 2.25
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci U S A (2007) 2.11
Regulatory T cells in cancer. Adv Cancer Res (2010) 2.02
Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A (2011) 1.97
High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res (2007) 1.96
The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol (2006) 1.95
Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res (2002) 1.90
Inflammation and cancer: how friendly is the relationship for cancer patients? Curr Opin Pharmacol (2009) 1.78
Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol (2007) 1.74
Cancer and inflammation: promise for biologic therapy. J Immunother (2010) 1.72
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival. J Pathol (2011) 1.69
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma. Gynecol Oncol (2007) 1.68
Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer (2008) 1.62
Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Ther (2010) 1.54
Inflammation and cancer: breast cancer as a prototype. Breast (2007) 1.52
Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer. Nat Rev Drug Discov (2013) 1.50
CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res Treat (2011) 1.43
Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer. Breast Cancer Res Treat (2008) 1.42
Multifaceted link between cancer and inflammation. Biosci Rep (2012) 1.39
Comparative expression pathway analysis of human and canine mammary tumors. BMC Genomics (2009) 1.35
Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. Clin Cancer Res (1997) 1.29
Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol Today (1999) 1.26
TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms. Cancer Discov (2011) 1.26
Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade. Histopathology (2011) 1.26
The immune system--is it relevant to cancer development, progression and treatment? Clin Oncol (R Coll Radiol) (2007) 1.24
The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase. Cancer (2005) 1.24
Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma. Int J Cancer (1997) 1.20
Different patterns of inflammation and prognosis in invasive carcinoma of the breast. Histopathology (2006) 1.19
The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer. Anticancer Res (2009) 1.18
Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance. Cancer Microenviron (2012) 1.15
Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis. Acta Oncol (2007) 1.13
The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. Br J Cancer (2008) 1.10
The role and regulation of human Th17 cells in tumor immunity. Am J Pathol (2012) 1.09
Comparative oncology today. Vet Clin North Am Small Anim Pract (2007) 1.09
Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer. Am J Clin Oncol (2013) 1.07
The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. Eur J Cancer (2009) 1.07
Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer. Breast (2008) 1.06
Canine mammary tumours as a model to study human breast cancer: most recent findings. In Vivo (2011) 1.02
Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity? Trends Mol Med (2012) 1.01
Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer. Oncology (1995) 0.99
Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes. Virology (2001) 0.99
Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast. Virchows Arch (2004) 0.99
Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Vet Immunol Immunopathol (2006) 0.97
Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates. BMC Cancer (2010) 0.97
Fractalkine expression in human renal inflammation. J Pathol (2002) 0.96
Breast cancer vaccines: a clinical reality or fairy tale? Ann Oncol (2005) 0.96
Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients. Cancer Immunol Immunother (1999) 0.95
Inflammation and cancer: a comparative view. J Vet Intern Med (2011) 0.94
Immune dysfunction and micrometastases in women with breast cancer. Breast Cancer Res Treat (2005) 0.93
Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms. Vet Pathol (2010) 0.90
The role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer. Cancer Treat Rev (2012) 0.90
Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement. Clinics (Sao Paulo) (2006) 0.89
Prognostic impact of FOXP3 expression in triple-negative breast cancer. Acta Oncol (2012) 0.89
Computerised counting of tumour infiltrating lymphocytes in 90 breast cancer specimens. Cancer Lett (1999) 0.86
Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma. J Vet Intern Med (2010) 0.86
Skewing the balance of regulatory T-cells and T-helper 17 cells in breast cancer patients. J Int Med Res (2011) 0.85
Phenotypical characterization of lymphocytes infiltrating regressing papillomas. J Virol (1996) 0.85
Immunohistochemical study of the local inflammatory infiltrate in spontaneous canine transmissible venereal tumour at different stages of growth. Vet Immunol Immunopathol (1998) 0.84
Of humans and canines: Immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours. Res Vet Sci (2006) 0.84
Correlation of Foxp3 positive regulatory T cells with prognostic factors in canine mammary carcinomas. Vet J (2011) 0.82
Compositional correlations in canine genome reflects similarity with human genes. J Biochem Mol Biol (2006) 0.81
Patterns of lymphoid infiltrate in the canine cutaneous histiocytoma. J Comp Pathol (1979) 0.81
T-lymphocytic infiltrate in canine mammary tumours: clinic and prognostic implications. In Vivo (2011) 0.80
Immunity and autoimmunity: revising the concepts of response to breast cancer. Breast (2011) 0.80
Discovery and development of therapeutic cancer vaccines. Curr Opin Drug Discov Devel (2007) 0.80
T-helper (Th)1/Th2 imbalance in the peripheral blood of dogs with malignant tumor. Microbiol Immunol (2007) 0.79
Significance of tumor-infiltrating immune cells in spontaneous canine mammary gland tumor: 140 cases. J Vet Med Sci (2011) 0.78
Decrease of E-cadherin expression in canine cutaneous histiocytoma appears to be related to its spontaneous regression. Anticancer Res (2009) 0.78
Immunohistochemical characterization of the leucocytic infiltrate associated with canine seminomas. J Comp Pathol (2004) 0.78
Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cells. Int J Cancer (2006) 0.77
Infiltrating Foxp3+ regulatory T cells and histopathological features in canine classical and spermatocytic seminomas. Reprod Domest Anim (2012) 0.77
Lymphocyte infiltration, expression of interleukin (IL) -1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours. J Comp Pathol (2009) 0.76
Correlation of tumor-infiltrating lymphocytes to histopathological features and molecular phenotypes in canine mammary carcinoma: A morphologic and immunohistochemical morphometric study. Can J Vet Res (2013) 0.76
Prognostic factors in breast-cancer (review). Int J Oncol (1992) 0.75
A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs. Biomed Res Int (2016) 0.75